Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_assertion type Assertion NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_head.
- NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_assertion description "[This study reveals a critical role for the PTEN/PI3K pathway in both SCLC and lung adenocarcinoma and provides an ideal system to test the phosphoinositide 3-kinase (PI3K) pathway inhibitors as targeted therapy for subsets of patients with SCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_provenance.
- NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_assertion evidence source_evidence_literature NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_provenance.
- NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_assertion SIO_000772 24482365 NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_provenance.
- NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_assertion wasDerivedFrom befree-2016 NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_provenance.
- NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_assertion wasGeneratedBy ECO_0000203 NP1150742.RA1YwZ0mewG1oXWYlHgHEH5iaba8oA9aQGi7uo72nJRDY130_provenance.